UN&UP – A company serving unmet needs and underserved populations
UN&UP is building tomorrow’s life-science technologies . . . today. Traditional dilutive pathways to early-stage capital are punitive. Securing IP rights and raising follow-on capital cannibalize the time and money needed to build a technology’s value proposition. As a result, risk to investors is increased, founder ownership is diluted, productivity is reduced, and control is lost. UN&UP’s model is different and builds upon proven start-up entrepreneurship, a deep understanding of intellectual property, and a long history of success with non-dilutive federal grant funding. Federal dollars are optimally leveraged among multiple efforts to result in the fast formation of healthy companies at Series A; with strong IP, greater founder ownership, and lower risk to investors. UN&UP’s experienced consulting arm helps institutions and companies build successful technologies around their respective needs, regardless of their for-profit or small business status.
-
Industry
-
Medical Equipment Manufacturing
-
Company size
-
2-10 employees
-
Headquarters
-
St. Louis, Missouri
-
Type
-
Privately Held
-
Founded
-
2018
-
Specialties
-
Life Sciences, Medical Devices, Biotech, Nanotechnology, Grant Funding, Start Ups, Clinical Relationships, Regulatory, Intellectual Property, and Venture Capital
